Average Co-Inventor Count = 3.58
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Dana-farber-cancer Institute Inc. (19 from 1,209 patents)
2. Harvard College (11 from 2,963 patents)
3. Acetylon Pharmaceuticals, Inc. (4 from 35 patents)
4. Colorado State University Research Foundation (3 from 470 patents)
5. University of Notre Dame Du Lac (2 from 368 patents)
6. Novartis Ag (1 from 3,923 patents)
7. The Brigham and Women's Hospital, Inc. (1 from 1,373 patents)
8. Children's Medical Center Corporation (1 from 1,036 patents)
9. Baylor College of Medicine (1 from 601 patents)
10. Howard Hughes Medical Institute (1 from 118 patents)
25 patents:
1. 12129248 - Chromobox protein inhibitors and uses thereof
2. 12023385 - Tunable endogenous protein degradation with heterobifunctional compounds
3. 11999802 - Compositions and methods for selective protein degradation
4. 11944625 - Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies
5. 11617750 - Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
6. 10525139 - Folate-conjugated molecules for delivery of toxic small molecule inhibitors to cancer cells and methods of use
7. 10172821 - Histone deacetylase inhibitors
8. 9789120 - Male contraceptive compositions and methods of use
9. 9724321 - Histone deacetylase inhibitors
10. 9434686 - Deacetylase inhibitors and uses thereof
11. 9199923 - Histone deacetylase inhibitors
12. 9186402 - Method for preparing largazole analogs and uses thereof
13. 9074009 - Stabilized MAML peptides and uses thereof
14. 8754237 - Bifunctional histone deacetylase inhibitors
15. 8716344 - Class- and isoform-specific HDAC inhibitors and uses thereof